Telling Our Daughters Our Story

Status Active, not recruiting

Clinical Trial Summary

The objective of this research study is to evaluate a culturally grounded program among American Indian (AI) female children and the children's female caregivers. This project will evaluate the impact of "Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (henceforth referred to as TODOS) on associated risk and protective factors for early substance use and sexual debut through a randomized controlled trial on the White Mountain Apache (WMA) reservation. The investigators will examine whether the TODOS program effectively reduces risk factors and improves protective factors associated with early substance use and sexual debut, with long term goals of reducing teen pregnancy and teen substance use.

Clinical Trial Description

The investigators will employ a randomized controlled trial (RCT) design to assess the preliminary impact of the TODOS program on many factors, including improving cultural knowledge, family engagement in Apache culture, mother daughter communication, self-esteem, self-efficacy, social support, attitudes about risky behaviors, and knowledge of reproductive health and substance use. Participants will be caregivers of girls ages 8-11 years. The TODOS program consists of 11 weekly sessions conducted with girls ages 8-11 and the girl's female caregivers. Five of the 11 sessions will be taught to small groups of girls and the girl's mothers, and 6 of the sessions will be taught to individual girl/female caregivers' dyads. The choice to use a mix of group- and home-based sessions is based on findings from the formative phase about preference that certain topics be taught in groups, and certain topics be taught in individual dyads. Each of the sessions (group and individual) will be 60-90 minutes in duration and delivered by a trained Family Health Coach (FHC). The investigators will enroll up to 94 dyads into four cohorts, each consisting of 18-26 dyads. Dyads will receive either the TODOS program or a control condition. The control condition will consist of 3 group sessions delivered monthly for three months. The investigators will evaluate the TODOS program's feasibility through process data including attendance forms and session summary feedback forms completed by the FHCs. The investigators will assess program acceptability immediately after program completion through implementation assessments completed by caregiver and children participants. The investigators will assess the program's impact on key outcomes immediately after program implementation, 6-month and 12-month post program implementation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06276595
Study type	Interventional
Source	Johns Hopkins Bloomberg School of Public Health
Contact
Status	Active, not recruiting
Phase	N/A
Start date	March 30, 2019
Completion date	July 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05806840` - Rapid Adaptation to Prevent Drug Use	N/A
Recruiting	`NCT06003725` - Cultural Adaptation of Drug Treatment for DJJ Youth	N/A
Recruiting	`NCT05414344` - A Brief Intervention for Alcohol Users With Interpersonal Trauma	N/A
Recruiting	`NCT05768815` - Optimizing Mental Health for Infants Exposed to Early Adversity: A Comparison of Breaking the Cycle and Maxxine Wright	N/A
Completed	`NCT05606601` - An Online Intervention Addressing Mental Health and Substance Use in University Students	N/A
Completed	`NCT03489434` - Technology-Based Prevention for Adolescents in Primary Care	N/A
Completed	`NCT04284813` - Families With Substance Use and Psychosis: A Pilot Study	N/A
Recruiting	`NCT05899101` - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed	`NCT02990026` - Specialty Mental Health Probation in North Carolina	N/A
Not yet recruiting	`NCT06116266` - Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)	N/A
Not yet recruiting	`NCT03249428` - E-Cigarette Inner City RCT	N/A
Active, not recruiting	`NCT03129334` - Preventing Prescription Drug Abuse in Middle School Students	N/A
Completed	`NCT04183400` - Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness	N/A
Completed	`NCT02112201` - The ProGirls Study	N/A
Completed	`NCT01752998` - Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings	N/A
Terminated	`NCT01661517` - Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting	Phase 0
Completed	`NCT01351454` - Behavioral Depression Treatment for African American HIV-infected Substance Users	N/A
Completed	`NCT01511380` - Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth	Phase 2
Completed	`NCT01154309` - Group CBT for Depression and AOD Disorders	Phase 1
Completed	`NCT00996541` - Support To Reunite Involve and Value Each Other	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Telling Our Daughters Our Story — TODOS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms